Trial Profile
A Retrospective, observational study of Dalfampridine and its effect on visual functions, fatigue and neuropathic pain in patients with Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2016
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 18 Nov 2016 New trial record